Risk of thromboembolic complications in patients with permanent atrial fibrillation undergoing cardioverter-defibrillator implantation

Kardiologia Polska

Volumn 57, Issue 10, 2002, Pages 306-309

  Przybylski, Andrzej ^a   Sterliński, Maciej ^a   Lewandowski, Michał ^a   Srzednicki, Marek ^a   Wolski, Piotr ^a   Macia̧g, Aleksander ^a   Pytkowski, Mariusz ^a   Kowalik, Ilona ^a   Szwed, Hanna ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Atrial fibrillation; Cardioversion; ICD implantation; Thromboembolic risk

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVERSION; DEFIBRILLATOR; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEMATOMA; HEPARINIZATION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; PATIENT SELECTION; PERIOPERATIVE PERIOD; RISK ASSESSMENT; SINUS RHYTHM; STANDARD; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0036806180     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Arnold A.Z., Mick M.J., Mazurek R.P. et al.: Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J. Am. Coll. Cardiol. 1992, 19, 851-855.
2. Fuster V., Ryden L.E., Asinger R.W. et al.: ACC/AHA/ECC guidelines for the management of patients with atrial fibrillation: Executive summary: A report of the American College of Cardiololgy/American Heart Association Task Force on Practical Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 2001, 38, 1231-1265.
3. Polskie Towarzystwo Kardiologiczne. Standardy postȩpowania w chorobach układu kra̧żenia. Nadkomorowe zaburzenia rytmu serca. Kardiol. Pol. 1997, XLVI (suplement I), 51-64.
4. Lehmann M.H., Steinman R.T., Schugar C.D. et al.: Defibrillation threshold testing and other practices related to AICD implantation: Do all roads lead to Rome? PACE 1989, 12, 1530-1535.
5. Potratz J.: Defibrillationsschwellenbestimmung. W Wietholt D., Ulbricht L.J., Gülker H. Implantierbare Kardioverter-Defibrillatoren. Georg Thieme Verlag. Stuttgart, New York 1997, 64-72.
6. Alt E., Ammer R., Schmidtt C. et al.: A comparison of treatment of atrial fibrillation with low energy intracardiac cardioversion and conventional external cardioversion. Eur. Heart J. 1997, 18, 1796-804.
7. Rosenquist M., Beyer T., Block M. et al.: Adverse events with transvenous implantable cardioverter-defibrillators. A prospective multicenter study. Circulation 1998;98:663-670.
8. Raviele A., Gasparini G., for the Italian Endotak Investigator Group. Italian multicenter clinical experience with endocardial defibrillation: Acute and long term results in 307 patients. PACE 1995, 18 (III), 599-608.
9. Hoffmann E., Steinbeck G. for European Jewel Investigators. Experience with pectoral versus abdominal implantations of a small defibrillator. Eur. Heart J. 1998, 1085-1098.
10. Sra J.S., Natale A., Axtell K. et al.: Experience with two different nonthoracotomy systems for implantable defibrillators. PACE 1994, 17, 1741-1750.
11. Gregoratos G., Cheitlin M.D., Conill A. et al.: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarhythmics devices: A report of the ACC/AHA Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 1998, 31, 1175-1206.